Achieve Life Sciences
ACHV
#8194
Rank
โ‚น22.49 B
Marketcap
โ‚น422.57
Share price
1.52%
Change (1 day)
9.45%
Change (1 year)

Revenue for Achieve Life Sciences (ACHV)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Achieve Life Sciences from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2016 โ‚น0.34 B-71.5%
2015 โ‚น1.20 B-29.78%
2014 โ‚น1.71 B-6.91%
2013 โ‚น1.84 B67.79%
2012 โ‚น1.10 B278.44%
2011 โ‚น0.29 B-52.35%
2010 โ‚น0.61 B-48.51%
2009 โ‚น1.18 B
2007 โ‚น0.79 B-20.34%
2006 โ‚น0.99 B
2001 โ‚น0.42 B2114.61%
2000 โ‚น19.06 M-97.44%
1999 โ‚น0.74 B242.81%
1998 โ‚น0.21 B-70.8%
1997 โ‚น0.74 B24.47%
1996 โ‚น0.59 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
โ‚น12.53 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas